Home›Companies›Biotech & Pharma›Khona Scientific

Khona Scientific Holdings, Inc.

Develops biological manufacturing technology for pharmaceutical ingredients and their starting materials.

Updated Nov 9, 2026·Latest SEC filing Oct 6, 2026·Suggest an edit

About Khona Scientific

Khona Scientific is a private company based in Lone Tree, Colorado, incorporated in 2021 in Delaware. It has reported $5,836,007 raised in three offerings on Form D since November 2021. Its chief executive is Paul Orlady.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 16, 2025Apr 28, 2025amended Oct 6, 2026$3,183,000fully sold11$289KConvertible promissory notesRule 506(b)Form D/A ↗2 earlier filings
Nov 21, 2022Nov 21, 2022amended Apr 22, 2025$2,142,007fully sold9$238KEquityRule 506(b)Form D/A ↗1 earlier filing
Nov 17, 2021Nov 30, 2021amended Nov 21, 2022$511,000fully sold8$63,875Debt, OptionsRule 506(b)Form D/A ↗1 earlier filing
Total, three offerings$5,836,007

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Khona Scientific's Form D filed Oct 6, 2026.

PO
Paul Orlady
CEO; Co-Founder and director
DO
Dylan Orlady
COO; Co-Founder and director
JB
Jordan Buck
CSO; Co-Founder and director
JS

Earlier filings also listed Doug Hannah (director, last listed Apr 2025).

Sources

  1. SECKhona Scientific Holdings, Inc. Form D/A, filed Aug 31, 2026
  2. SECKhona Scientific Holdings, Inc. Form D, filed Apr 28, 2025
  3. SECKhona Scientific Holdings, Inc. Form D, filed Nov 21, 2022
  4. SECKhona Scientific Holdings, Inc. Form D, filed Nov 30, 2021
  5. SECKhona Scientific Holdings, Inc. filing history
  6. CompanyKhona Scientific about